Tao X, Cai L, Chen L, Ge S, Deng X
Fish rich in omega-3 polyunsaturated fats (salmon, sardines, mackerel) demonstrate associations with improved metabolic hormone profiles in observational research
Implications of new evidence from cardiovascular outcomes trials The major change from prior consensus reports is based on new evidence that specific sodiumglucose cotransporter-2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists improve cardiovascular outcomes, as well as secondary outcomes such as HF and progression of renal disease, in patients with established CVD or CKD
Mistake 5: Falling for "natural GLP-1" marketing language The phrase "natural GLP-1" has become a marketing weapon
Oxid Med Cell Longev (2020) 2020:3580719
At Family Care of Murphy, Dr